MedAdvisor to formally review its market value


The global pharmacy software company’s board has brought in financial advisors and legal counsel to help “ensure (their) assets are assigned their full and appropriate value”  The board of software business MedAdvisor believes there’s a “valuation disconnect” between how it’s trading and its actual value, prompting it to formally review how to maximise its shareholder returns.  

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous What does the future look like for CWH/Sigma shareholders?
Next TGA withdraws InstantScripts infringement notices